Annual Current Liabilities
$17.88 M
+$9.49 M+112.97%
December 31, 2023
Summary
- As of March 10, 2025, OPRX annual total current liabilities is $17.88 million, with the most recent change of +$9.49 million (+112.97%) on December 31, 2023.
- During the last 3 years, OPRX annual current liabilities has risen by +$7.85 million (+78.31%).
- OPRX annual current liabilities is now at all-time high.
Performance
OPRX Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Current Liabilities
$14.50 M
-$454.00 K-3.04%
September 30, 2024
Summary
- As of March 10, 2025, OPRX quarterly total current liabilities is $14.50 million, with the most recent change of -$454.00 thousand (-3.04%) on September 30, 2024.
- Over the past year, OPRX quarterly current liabilities has stayed the same.
- OPRX quarterly current liabilities is now -18.90% below its all-time high of $17.88 million, reached on December 31, 2023.
Performance
OPRX Quarterly Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Current Liabilities Formula
Current Liabilities = Accounts Payable + Short-Term Debt + Accrued Expenses + Other Current Liabilities
OPRX Current Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +113.0% | 0.0% |
| 3 y3 years | +78.3% | +54.8% |
| 5 y5 years | +322.6% | +137.4% |
OPRX Current Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +113.0% | -18.9% | +163.2% |
| 5 y | 5-year | at high | +192.8% | -18.9% | +167.1% |
| alltime | all time | at high | >+9999.0% | -18.9% | >+9999.0% |
OptimizeRx Current Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $14.50 M(-3.0%) |
| Jun 2024 | - | $14.96 M(-10.8%) |
| Mar 2024 | - | $16.77 M(-6.2%) |
| Dec 2023 | $17.88 M(+113.0%) | $17.88 M(+132.2%) |
| Sep 2023 | - | $7.70 M(+39.8%) |
| Jun 2023 | - | $5.51 M(-27.6%) |
| Mar 2023 | - | $7.61 M(-9.4%) |
| Dec 2022 | $8.40 M(-10.4%) | $8.40 M(+36.9%) |
| Sep 2022 | - | $6.13 M(-4.8%) |
| Jun 2022 | - | $6.44 M(-6.3%) |
| Mar 2022 | - | $6.88 M(-26.6%) |
| Dec 2021 | $9.37 M(-6.6%) | $9.37 M(+23.7%) |
| Sep 2021 | - | $7.57 M(+13.6%) |
| Jun 2021 | - | $6.67 M(+22.7%) |
| Mar 2021 | - | $5.43 M(-45.8%) |
| Dec 2020 | $10.03 M(+64.2%) | $10.03 M(+23.6%) |
| Sep 2020 | - | $8.11 M(-33.3%) |
| Jun 2020 | - | $12.17 M(+28.5%) |
| Mar 2020 | - | $9.47 M(+55.1%) |
| Dec 2019 | $6.11 M(+44.3%) | $6.11 M(+12.9%) |
| Sep 2019 | - | $5.41 M(-4.6%) |
| Jun 2019 | - | $5.67 M(+47.1%) |
| Mar 2019 | - | $3.86 M(-8.9%) |
| Dec 2018 | $4.23 M(+19.4%) | $4.23 M(+65.5%) |
| Sep 2018 | - | $2.56 M(-10.1%) |
| Jun 2018 | - | $2.84 M(+16.6%) |
| Mar 2018 | - | $2.44 M(-31.2%) |
| Dec 2017 | $3.54 M(-3.4%) | $3.54 M(-5.8%) |
| Sep 2017 | - | $3.76 M(-6.1%) |
| Jun 2017 | - | $4.01 M(+3.7%) |
| Mar 2017 | - | $3.87 M(+5.4%) |
| Dec 2016 | $3.67 M | $3.67 M(+13.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2016 | - | $3.22 M(+13.4%) |
| Jun 2016 | - | $2.84 M(+11.4%) |
| Mar 2016 | - | $2.55 M(-24.3%) |
| Dec 2015 | $3.37 M(+39.4%) | $3.37 M(+9.5%) |
| Sep 2015 | - | $3.08 M(+35.1%) |
| Jun 2015 | - | $2.28 M(+4.5%) |
| Mar 2015 | - | $2.18 M(-9.8%) |
| Dec 2014 | $2.42 M(+5.9%) | $2.42 M(+58.9%) |
| Sep 2014 | - | $1.52 M(+2.7%) |
| Jun 2014 | - | $1.48 M(-22.5%) |
| Mar 2014 | - | $1.91 M(-16.3%) |
| Dec 2013 | $2.28 M(+196.5%) | $2.28 M(+201.5%) |
| Sep 2013 | - | $757.70 K(+6.4%) |
| Jun 2013 | - | $712.30 K(-5.2%) |
| Mar 2013 | - | $751.20 K(-2.5%) |
| Dec 2012 | $770.50 K(-40.9%) | $770.50 K(-13.4%) |
| Sep 2012 | - | $890.20 K(-13.1%) |
| Jun 2012 | - | $1.02 M(+7.9%) |
| Mar 2012 | - | $949.50 K(-27.1%) |
| Dec 2011 | $1.30 M(+52.5%) | $1.30 M(+76.3%) |
| Sep 2011 | - | $739.40 K(-14.3%) |
| Jun 2011 | - | $862.60 K(-1.4%) |
| Mar 2011 | - | $874.60 K(+2.3%) |
| Dec 2010 | $854.80 K(+2161.4%) | $854.80 K(+36.2%) |
| Sep 2010 | - | $627.40 K(+1.1%) |
| Jun 2010 | - | $620.80 K(+4366.2%) |
| Mar 2010 | - | $13.90 K(-63.2%) |
| Dec 2009 | $37.80 K(-82.6%) | $37.80 K(+220.3%) |
| Sep 2009 | - | $11.80 K(-75.6%) |
| Jun 2009 | - | $48.30 K(-75.0%) |
| Mar 2009 | - | $193.10 K(-11.3%) |
| Dec 2008 | $217.80 K(-35.9%) | $217.80 K |
| Dec 2007 | $339.90 K | - |
FAQ
- What is OptimizeRx annual total current liabilities?
- What is the all time high annual current liabilities for OptimizeRx?
- What is OptimizeRx annual current liabilities year-on-year change?
- What is OptimizeRx quarterly total current liabilities?
- What is the all time high quarterly current liabilities for OptimizeRx?
- What is OptimizeRx quarterly current liabilities year-on-year change?
What is OptimizeRx annual total current liabilities?
The current annual current liabilities of OPRX is $17.88 M
What is the all time high annual current liabilities for OptimizeRx?
OptimizeRx all-time high annual total current liabilities is $17.88 M
What is OptimizeRx annual current liabilities year-on-year change?
Over the past year, OPRX annual total current liabilities has changed by +$9.49 M (+112.97%)
What is OptimizeRx quarterly total current liabilities?
The current quarterly current liabilities of OPRX is $14.50 M
What is the all time high quarterly current liabilities for OptimizeRx?
OptimizeRx all-time high quarterly total current liabilities is $17.88 M
What is OptimizeRx quarterly current liabilities year-on-year change?
Over the past year, OPRX quarterly total current liabilities has changed by $0.00 (0.00%)